Delivery Order SPE2DB20D3101-SPE2DB25FRBT8
Award Date
2/12/25
Potential Completion Date
2/13/25
Potential Value
$6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,024.26 firm fixed price delivery order is for the supply of 4565123421 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to...
This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRVV4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,420.48 firm fixed-price delivery order is for the supply of 4565911768 CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, with a final completion date of September 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,218.12 firm fixed-price delivery order covers the supply of 4564465555 - CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a specialty medication, with a completion date of May 2, 2024. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,275.60 fixed-price delivery order is for the supply of 4563636579 CLOBAZAM 10 MG TABLET 100S, with a completion date of February 13, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $18,815.01, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The award is for the delivery of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has a performance period ending on July 22, 2024 and utilizes a Firm Fixed Price pricing structure. This award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,796.51 Firm Fixed Price delivery order contract is for the supply of 4566848926 CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, with a ceiling value of $1,200.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of CLOBAZAM 2.5 MG/ML SUSPENSION 120ML, a pharmaceutical product. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,831.20 firm fixed-price delivery order is for the supply of 4566691271 - CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $2,093.59 with a firm fixed price, and a completion date of January 7, 2025. The contract is for the delivery of 4566847098 - CLOBAZAM 10 MG TABLET 100S, and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm-fixed-price delivery order, valued at $2,042.53, is for the supply of CLOBAZAM 10 MG TABLET 100S. This award is not associated with a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...